Finite Element Analysis of Denosumab Treatment Effects on Vertebral Strength in Ovariectomized Cynomolgus Monkeys

Journal of Bone and Mineral Research

Volumn 31, Issue 8, 2016, Pages 1586-1595

  Lee, David C ^a   Varela, Aurore ^b   Kostenuik, Paul J ^c   Ominsky, Michael S ^d   Keaveny, Tony M ^e  

^a ON Diagnostics   (United States)

^b CHARLES RIVER LABORATORIES   (United States)

^c Phylon Pharma Services   (United States)

^d AMGEN INC   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ANTIRESORPTIVES; BIOMECHANICS; BONE STRENGTH; OSTEOPOROSIS; TREATMENT

Indexed keywords

DENOSUMAB;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE MASS; BONE MICROARCHITECTURE; BONE STRENGTH; COMPRESSIVE STRENGTH; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; CORTICAL THICKNESS (BONE); DRUG MECHANISM; FEMALE; FINITE ELEMENT ANALYSIS; FRACTURE; HUMAN; HUMAN TISSUE; IMAGE PROCESSING; MACACA FASCICULARIS; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; OVARIECTOMY; POROSITY; QUANTITATIVE ANALYSIS; SHAM PROCEDURE; THORACIC VERTEBRA; TRABECULAR BONE; VERTEBRA;

EID: 84980048087     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2830     Document Type: Article

References (68)

1. Bouxsein ML, Seeman E. Quantifying the material and structural determinants of bone strength. Best Pract Res Clin Rheumatol. 2009; 23(6):741–53.
2. Bauer JS, Kohlmann S, Eckstein F, et al. Structural analysis of trabecular bone of the proximal femur using multislice computed tomography: a comparison with dual x-ray absorptiometry for predicting biomechanical strength in vitro. Calcif Tissue Int. 2006; 78(2):78–89.
3. Nawathe S, Akhlaghpour H, Bouxsein ML, Keaveny TM. Microstructural failure mechanisms in the human proximal femur for sideways fall loading. J Bone Miner Res. 2014; 29(2):507–15.
4. Fields AJ, Lee GL, Liu XS, et al. Influence of vertical trabeculae on the compressive strength of the human vertebra. J Bone Miner Res. 2011; 26(2):263–9.
5. Faulkner KG, Gluer CC, Majumdar S, et al. Noninvasive measurements of bone mass, structure, and strength: current methods and experimental techniques. AJR Am J Roentgenol. 1991; 157(6):1229–37.
6. Keaveny TM. Biomechanical computed tomography-noninvasive bone strength analysis using clinical computed tomography scans. Ann N Y Acad Sci. 2010; 1192:57–65.
7. Zysset PK, Dall'ara E, Varga P, Pahr DH. Finite element analysis for prediction of bone strength. Bonekey Rep. 2013; 2:386.
8. Keyak JH, Fourkas MG, Meagher JM, Skinner HB. Validation of an automated-method of 3-dimensional finite-element modeling of bone. J Biomed Eng. 1993; 15(6):505–9.
9. Wang X, Sanyal A, Cawthon PM, et al. Prediction of new clinical vertebral fractures in elderly men using finite element analysis of CT scans. J Bone Miner Res. 2012; 27(4):808–16.
10. Roberts BJ, Kopperdahl DL, Thrall E, et al. Prediction of femoral strength in a sideways fall configuration using QCT-based finite element analysis. Bone. 2009;S72. [Joint Meeting of the International Bone & Mineral Society and the Australian & New Zealand Bone & Mineral Society; Mar 21–25, 2009; Sydney, Australia].
11. Melton LJ, Riggs BL, Keaveny TM, et al. Structural determinants of vertebral fracture risk. J Bone Miner Res. 2007; 22(12):1885–92.
12. Faulkner KG, Cann CE, Hasegawa BH. Effect of bone distribution on vertebral strength: assessment with patient-specific nonlinear finite element analysis. Radiology. 1991; 179(3):669–74.
13. Melton LJ 3rd, Riggs BL, Keaveny TM, et al. Relation of vertebral deformities to bone density, structure, and strength. J Bone Miner Res. 2010; 25(9):1922–30.
14. Imai K, Ohnishi I, Matsumoto T, Yamamoto S, Nakamura K. Assessment of vertebral fracture risk and therapeutic effects of alendronate in postmenopausal women using a quantitative computed tomography-based nonlinear finite element method. Osteoporos Int. 2009; 20(5):801–10.
15. Anderson DE, Demissie S, Allaire BT, et al. The associations between QCT-based vertebral bone measurements and prevalent vertebral fractures depend on the spinal locations of both bone measurement and fracture. Osteoporos Int. 2014; 25(2):559–66.
16. Kopperdahl DL, Aspelund T, Hoffmann PF, et al. Assessment of incident spine and hip fractures in women and men using finite element analysis of CT scans. J Bone Miner Res. 2014; 29(3):570–80.
17. Keyak JH, Sigurdsson S, Karlsdottir G, et al. Male-female differences in the association between incident hip fracture and proximal femoral strength: a finite element analysis study. Bone. 2011; 48(6):1239–45.
18. Orwoll ES, Marshall LM, Nielson CM, et al. Finite element analysis of the proximal femur and hip fracture risk in older men. J Bone Miner Res. 2009; 24(3):475–83.
19. Amin S, Kopperdahl DL, Melton LJ 3rd, et al. Association of hip strength estimates by finite-element analysis with fractures in women and men. J Bone Miner Res. 2011; 26(7):1593–600.
20. Chevalier Y, Quek E, Borah B, et al. Biomechanical effects of teriparatide in women with osteoporosis treated previously with alendronate and risedronate: results from quantitative computed tomography-based finite element analysis of the vertebral body. Bone. 2010; 46(1):41–8.
21. Graeff C, Chevalier Y, Charlebois M, et al. Improvements in vertebral body strength under teriparatide treatment assessed in vivo by finite element analysis: results from the EUROFORS study. J Bone Miner Res. 2009; 24(10):1672–80.
22. Imai K. Vertebral fracture risk and alendronate effects on osteoporosis assessed by a computed tomography-based nonlinear finite element method. J Bone Miner Metab. 2011; 29(6):645–51.
23. Gluer CC, Marin F, Ringe JD, et al. Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial. J Bone Miner Res. 2013; 28(6):1355–68.
24. Keaveny TM, Donley DW, Hoffmann PF, et al. Effects of teriparatide and alendronate on vertebral strength as assessed by finite element modeling of QCT scans in women with osteoporosis. J Bone Miner Res. 2007; 22(1):149–57.
25. Mawatari T, Miura H, Hamai S, et al. Vertebral strength changes in rheumatoid arthritis patients treated with alendronate, as assessed by finite element analysis of clinical computed tomography scans: a prospective randomized clinical trial. Arthritis Rheum. 2008; 58(11):3340–9.
26. Keaveny TM, Hoffmann PF, Singh M, et al. Femoral bone strength and its relation to cortical and trabecular changes after treatment with PTH, alendronate, and their combination as assessed by finite element analysis of quantitative CT scans. J Bone Miner Res. 2008; 23(12):1974–82.
27. Lewiecki EM, Keaveny TM, Kopperdahl DL, et al. Once-monthly oral Ibandronate improves biomechanical determinants of bone strength in women with postmenopausal osteoporosis. J Clin Endocrinol Metab. 2009; 94(1):171–80.
28. Keaveny TM, McClung MR, Wan X, et al. Femoral strength in osteoporotic women treated with teriparatide or alendronate. Bone. 2012; 50(1):165–70.
29. Brixen K, Chapurlat R, Cheung AM, et al. Bone density, turnover, and estimated strength in postmenopausal women treated with odanacatib: a randomized trial. J Clin Endocrinol Metab. 2013; 98(2):571–80.
30. Cosman F, Keaveny TM, Kopperdahl D, et al. Hip and spine strength effects of adding versus switching to teriparatide in postmenopausal women with osteoporosis treated with prior alendronate or raloxifene. J Bone Miner Res. 2013; 28(6):1328–36.
31. Keaveny TM, McClung MR, Genant HK, et al. Femoral and vertebral strength improvements in postmenopausal women with osteoporosis treated with denosumab. J Bone Miner Res. 2014; 29(1):158–65.
32. Orwoll ES, Shapiro J, Veith S, et al. Evaluation of teriparatide treatment in adults with osteogenesis imperfecta. J Clin Invest. 2014; 124(2):491–8.
33. Kleerekoper M, Greenspan SL, Lewiecki EM, et al. Assessing the effects of teriparatide treatment on bone mineral density, bone microarchitecture, and bone strength. J Bone Joint Surg Am. 2014; 96(11):e90.
34. Zysset P, Pahr D, Engelke K, et al. Comparison of proximal femur and vertebral body strength improvements in the FREEDOM trial using an alternative finite element methodology. Bone. 2015; 81:122–30.
35. Ominsky MS, Stouch B, Schroeder J, et al. Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys. Bone. 2011; 49(2):162–73.
36. Danielson ME, Beck TJ, Karlamangla AS, et al. A comparison of DXA and CT based methods for estimating the strength of the femoral neck in post-menopausal women. Osteoporos Int. 2013; 24(4):1379–88.
37. Fidler JL, Murthy NS, Khosla S, et al. Comprehensive assessment of osteoporosis and bone fragility with CT colonography. Radiology. 2016; 278(1):172–80.
38. Weber NK, Fidler JL, Keaveny TM, et al. Validation of a CT-derived method for osteoporosis screening in IBD patients undergoing contrast-enhanced CT enterography. Am J Gastroenterol. 2014; 109(3):401–8.
39. Buie HR, Campbell GM, Klinck RJ, MacNeil JA, Boyd SK. Automatic segmentation of cortical and trabecular compartments based on a dual threshold technique for in vivo micro-CT bone analysis. Bone. 2007; 41(4):505–15.
40. Keaveny TM, Pinilla TP, Crawford RP, Kopperdahl DL, Lou A. Systematic and random errors in compression testing of trabecular bone. J Orthop Res. 1997; 15:101–10.
41. Keaveny TM, Borchers RE, Gibson LJ, Hayes WC. Theoretical analysis of the experimental artifact in trabecular bone compressive modulus. J Biomech. 1993; 26(4–5):599–607.
42. Morgan EF, Bayraktar HH, Keaveny TM. Trabecular bone modulus-density relationships depend on anatomic site. J Biomech. 2003; 36(7):897–904.
43. Morgan EF, Keaveny TM. Dependence of yield strain of human trabecular bone on anatomic site. J Biomech. 2001; 34(5):569–77.
44. Bayraktar HH, Morgan EF, Niebur GL, et al. Comparison of the elastic and yield properties of human femoral trabecular and cortical bone tissue. J Biomech. 2004; 37(1):27–35.
45. Crawford RP, Brouwers J, Keaveny TM. Accurate prediction of vertebral strength using voxel-based non-linear finite element models. Trans Orthop Res Soc. 2004; 29:1123.
46. Fieller EC. The biological standardization of insulin. Supplement to the Journal of the Royal Statistical Society. Series B (Methodological). 1940; 7(1):1–64.
47. Ludbrook J. Statistical techniques for comparing measurers and methods of measurement: a critical review. Clin Exp Pharmacol Physiol. 2002; 29(7):527–36.
48. Keaveny TM. Mechanistic approaches to analysis of trabecular bone. Forma. 1997; 12:267–75.
49. Crawford RP, Cann CE, Keaveny TM. Finite element models predict in vitro vertebral body compressive strength better than quantitative computed tomography. Bone. 2003; 33(4):744–50.
50. Cabal A, Jayakar RY, Sardesai S, et al. High-resolution peripheral quantitative computed tomography and finite element analysis of bone strength at the distal radius in ovariectomized adult rhesus monkey demonstrate efficacy of odanacatib and differentiation from alendronate. Bone. 2013; 56(2):497–505.
51. Eswaran SK, Allen MR, Burr DB, Keaveny TM. A computational assessment of the independent contribution of changes in canine trabecular bone volume fraction and microarchitecture to increased bone strength with suppression of bone turnover. J Biomech. 2007; 40(15):3424–31.
52. Kostenuik PJ, Smith SY, Samadfam R, et al. Effects of denosumab, alendronate, or denosumab following alendronate on bone turnover, calcium homeostasis, bone mass and bone strength in ovariectomized cynomolgus monkeys. J Bone Miner Res. 2015; 30(4):657–69.
53. Kostenuik PJ, Smith SY, Jolette J, et al. Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody. Bone. 2011; 49(2):151–61.
54. Allen MR, Iwata K, Sato M, Burr DB. Raloxifene enhances vertebral mechanical properties independent of bone density. Bone. 2006; 39(5):1130–5.
55. Allen MR, Burr DB. Changes in vertebral strength-density and energy absorption-density relationships following bisphosphonate treatment in beagle dogs. Osteoporos Int. 2008; 19(1):95–9.
56. Eswaran SK, Gupta A, Adams MF, Keaveny TM. Cortical and trabecular load sharing in the human vertebral body. J Bone Miner Res. 2006; 21(2):307–14.
57. Easley SK, Chang MT, Shindich D, Hernandez CJ, Keaveny TM. Biomechanical effects of simulated resorption cavities in cancellous bone across a wide range of bone volume fractions. J Bone Miner Res. 2012; 27(9):1927–35.
58. Hernandez CJ, Gupta A, Keaveny TM. A biomechanical analysis of the effects of resorption cavities on cancellous bone strength. J Bone Miner Res. 2006; 21(8):1248–55.
59. Slyfield CR, Tkachenko EV, Fischer SE, et al. Mechanical failure begins preferentially near resorption cavities in human vertebral cancellous bone under compression. Bone. 2012; 50(6):1281–7.
60. Goff MG, Lambers FM, Nguyen TM, et al. Fatigue-induced microdamage in cancellous bone occurs distant from resorption cavities and trabecular surfaces. Bone. 2015; 79:8–14.
61. Allen MR, Burr DB. Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: what we think we know and what we know that we don't know. Bone. 2011; 49(1):56–65.
62. Ominsky MS, Li X, Asuncion FJ, et al. RANKL inhibition with osteoprotegerin increases bone strength by improving cortical and trabecular bone architecture in ovariectomized rats. J Bone Miner Res. 2008; 23(5):672–82.
63. Ominsky MS, Libanati C, Niu QT, et al. Sustained modeling-based bone formation during adulthood in cynomolgus monkeys may contribute to continuous BMD gains with denosumab. J Bone Miner Res. 2015; 30(7):1280–9.
64. Silva MJ, Wang C, Keaveny TM, Hayes WC. Direct and computed-Tomography thickness measurements of the human, lumbar vertebral shell and end-plate. Bone. 1994; 15(4):409–14.
65. Prevrhal S, Fox JC, Shepherd JA, Genant HK. Accuracy of CT-based thickness measurement of thin structures: modeling of limited spatial resolution in all three dimensions. Med Phys. 2003; 30(1):1–8.
66. Imai K, Ohnishi I, Bessho M, Nakamura K. Nonlinear finite element model predicts vertebral bone strength and fracture site. Spine. 2006; 31(16):1789–94.
67. Fields AJ, Nawathe S, Eswaran SK, et al. Vertebral fragility and structural redundancy. J Bone Miner Res. 2012; 27(10):2152–8.
68. Dall'Ara E, Pahr D, Varga P, Kainberger F, Zysset P. QCT-based finite element models predict human vertebral strength in vitro significantly better than simulated DEXA. Osteoporos Int. 2012; 23(2):563–72.